Intravitreal Aflibercept for Diabetic Macular Edema
Keywords: CST; 2q4; 2 mg every 4 weeks; 2q8; 2 mg every 8 weeks after 5 initial monthly doses; AE; adverse event; aLOCF; last observation carried forward, including measurements after rescue treatment was given; BCVA; best-corrected visual acuity; CST; central (optical